Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program

Genes and Development

Volumn 20, Issue 5, 2006, Pages 601-612

  Gomes, Nathan P ^b   Bjerke, Glen ^b   Llorente, Briardo ^a   Szostek, Stephanie A ^b   Emerson, Beverly M ^a   Espinosa, Joaquin M ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; P TEFb; p21 gene; p53 tumor suppressor protein; RNA polymerase II; Transcription elongation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; ELONGATION FACTOR; FACILITATES CHROMATIN TRANSCRIPTION PROTEIN; MESSENGER RNA; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN P53; RNA POLYMERASE II; SERINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE LOCUS; GENE TARGETING; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA CLEAVAGE; RNA TRANSCRIPTION;

APOPTOSIS; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; DNA-BINDING PROTEINS; DOXORUBICIN; FLOW CYTOMETRY; HCT116 CELLS; HIGH MOBILITY GROUP PROTEINS; HUMANS; KINETICS; NUCLEAR PROTEINS; PHOSPHORYLATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA POLYMERASE II; SERINE; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ELONGATION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644787084     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1398206     Document Type: Article

References (50)

1. Adamson, T.E., Shutt, D.C., and Price, D.H. 2005. Functional coupling of cleavage and polyadenylation with transcription of mRNA. J. Biol. Chem. 280: 32262-32271.
2. Ahn, S.H., Kim, M., and Buratowski, S. 2004. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3′ end processing. Mol. Cell 13: 67-76.
3. Bentley, D.L. 2005. Rules of engagement: Co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol. 17: 251-256.
4. Bird, G., Zorio, D.A., and Bentley, D.L. 2004. RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3′-end formation. Mol. Cell. Biol. 24: 8963-8969.
5. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W., and Vogelstein, B. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
6. Chao, S.H. and Price, D.H. 2001. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J. Biol. Chem. 276: 31793-31799.
7. Chipuk, J.E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D.D., and Green, D.R. 2005. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309: 1732-1735.
8. Cho, E.J., Kobor, M.S., Kim, M., Greenblatt, J., and Buratowski, S. 2001. Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes & Dev. 15: 3319-3329.
9. Dai, Y. and Grant, S. 2003. Cyclin-dependent kinase inhibitors. Curr. Opin. Pharmacol. 3: 362-370.
10. el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
11. Erster, S. and Moll, U.M. 2004. Stress-induced p53 runs a direct mitochondrial death program: Its role in physiologic and pathophysiologic stress responses in vivo. Cell Cycle 3: 1492-1495.
12. Espinosa, J.M., Verdun, R.E., and Emerson, B.M. 2003. p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol. Cell 12: 1015-1027.
13. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., and Prives, C. 1992. Wild-type p53 activates transcription in vitro. Nature 358: 83-86.
14. Garber, M.E., Mayall, T.P., Suess, E.M., Meisenhelder, J., Thompson, N.E., and Jones, K.A. 2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20: 6958-6969.
15. Gerber, M. and Shilatifard, A. 2003. Transcriptional elongation by RNA polymerase II and histone methylation. J. Biol. Chem. 278: 26303-26306.
16. Hatzis, P. and Talianidis, I. 2002. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell 10: 1467-1477.
17. Hirose, Y. and Manley, J.L. 2000. RNA polymerase II and the integration of nuclear events. Genes & Dev. 14: 1415-1429.
18. Ho, C.K. and Shuman, S. 1999. Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol. Cell 3: 405-411.
19. Jones, J.C., Phatnani, H.P., Haystead, T.A., MacDonald, J.A., Alam, S.M., and Greenleaf, A.L. 2004. C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J. Biol. Chem. 279: 24957-24964.
20. Kern, S.E., Kinzler, K.W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252: 1708-1711.
21. Kim, M., Ahn, S.H., Krogan, N.J., Greenblatt, J.F., and Buratowski, S. 2004. Transitions in RNA polymerase II elongation complexes at the 3′ ends of genes. EMBO J. 23: 354-364.
22. Kizer, K.O., Phatnani, H.P., Shibata, Y., Hall, H., Greenleaf, A.L., and Strahl, B.D. 2005. A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with transcript elongation. Mol. Cell. Biol. 25: 3305-3316.
23. Kobor, M.S. and Greenblatt, J. 2002. Regulation of transcription elongation by phosphorylation. Biochim. Biophys. Acta 1577: 261-275.
24. Komarnitsky, P., Cho, E.J., and Buratowski, S. 2000. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes & Dev. 14: 2452-2460.
25. Krishnamurthy, S., He, X., Reyes-Reyes, M., Moore, C., and Hampsey, M. 2004. Ssu72 is an RNA polymerase II CTD phosphatase. Mol. Cell 14: 387-394.
26. Lam, L.T., Pickeral, O.K., Peng, A.C., Rosenwald, A., Hurt, E.M., Giltnane, J.M., Averett, L.M., Zhao, H., Davis, R.E., Sathyamoorthy, M., et al. 2001. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2: RESEARCH0041.
27. Ljungman, M., Zhang, F., Chen, F., Rainbow, A.J., and McKay, B.C. 1999. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18: 583-592.
28. Luecke, H.F. and Yamamoto, K.R. 2005. The glucocorticoid receptor blocks P-TEFb recruitment by NFκB to effect promoter-specific transcriptional repression. Genes & Dev. 19: 1116-1127.
29. Marshall, N.F., Peng, J., Xie, Z., and Price, D.H. 1996. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271: 27176-27183.
30. Ni, Z., Schwartz, B.E., Werner, J., Suarez, J.R., and Lis, J.T. 2004. Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. Mol. Cell 13: 55-65.
31. Orphanides, G., Wu, W.H., Lane, W.S., Hampsey, M., and Reinberg, D. 1999. The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. Nature 400: 284-288.
32. Price, D.H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20: 2629-2634.
33. Proudfoot, N.J., Furger, A., and Dye, M.J. 2002. Integrating mRNA processing with transcription. Cell 108: 501-512.
34. Ramanathan, Y., Rajpara, S.M., Reza, S.M., Lees, E., Shuman, S., Mathews, M.B., and Pe'ery, T. 2001. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J. Biol. Chem. 276: 10913-10920.
35. Richter, J.D. 1999. Cytoplasmic polyadenylation in development and beyond. Microbiol. Mol. Biol. Rev. 63: 446-456.
36. Rickert, P., Corden, J.L., and Lees, E. 1999. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18: 1093-1102.
37. Shim, E.Y., Walker, A.K., Shi, Y., and Blackwell, T.K. 2002. CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes & Dev. 16: 2135-2146.
38. Sims III, R.J., Belotserkovskaya, R., and Reinberg, D. 2004. Elongation by RNA polymerase II: The short and long of it. Genes & Dev. 18: 2437-2468.
39. Trigon, S., Serizawa, H., Conaway, J.W., Conaway, R.C., Jackson, S.P., and Morange, M. 1998. Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases. J. Biol. Chem. 273: 6769-6775.
40. Vogelstein, B., Lane, D., and Levine, A.J. 2000. Surfing the p53 network. Nature 408: 307-310.
41. Vousden, K.H. 2002. Activation of the p53 tumor suppressor protein. Biochim. Biophys. Acta 1602: 47-59.
42. Vousden, K.H. and Lu, X. 2002. Live or let die: The cell's response to p53. Nat. Rev. Cancer 2: 594-604.
43. Wada, T., Takagi, T., Yamaguchi, Y., Watanabe, D., and Handa, H. 1998. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17: 7395-7403.
44. Wang, Q., Carroll, J.S., and Brown, M. 2005. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell 19: 631-642.
45. Xiao, T., Kao, C.F., Krogan, N.J., Sun, Z.W., Greenblatt, J.F., Osley, M.A., and Strahl, B.D. 2005. Histone H2B ubiquitylation is associated with elongating RNA polymerase II. Mol. Cell. Biol. 25: 637-651.
46. Yamaguchi, Y., Takagi, T., Wada, T., Yano, K., Furuya, A., Sugimoto, S., Hasegawa, J., and Handa, H. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41-51.
47. Yeo, M., Lin, P.S., Dahmus, M.E., and Gill, G.N. 2003. A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J. Biol. Chem. 278: 26078-26085.
48. Zawel, L., Kumar, K.P., and Reinberg, D. 1995. Recycling of the general transcription factors during RNA polymerase II transcription. Genes & Dev. 9: 1479-1490.
49. Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W.H., Tom, E., Mack, D.H., and Levine, A.J. 2000. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes & Dev. 14: 981-993.
50. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M.B., and Price, D.H. 1997. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes & Dev. 11: 2622-2632.